Stay updated on Enhancing Antitumor Immunity with Electroporation Clinical Trial
Sign up to get notified when there's something new on the Enhancing Antitumor Immunity with Electroporation Clinical Trial page.

Latest updates to the Enhancing Antitumor Immunity with Electroporation Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe clinical trial record for the study is now available, with details on its design, treatment arms, eligibility, outcomes, investigators, and record history. It indicates that the trial was terminated because the treatment was ineffective and is no longer recruiting participants.SummaryDifference69%

- Check18 days agoChange DetectedThe page remains a 403 Forbidden error rather than displaying the clinical study record. The footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check25 days agoChange DetectedA site-wide NIH notice announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check32 days agoChange DetectedThe site revision displayed in the footer changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details, indicating the record is currently inaccessible.SummaryDifference22%

Stay in the know with updates to Enhancing Antitumor Immunity with Electroporation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enhancing Antitumor Immunity with Electroporation Clinical Trial page.